Death rates from heart disease in the European Union have more than halved in many countries since the early 1980s, according to new research published in the European Heart Journal [1]. In the majority of countries, there have been ongoing steady reductions in heart disease death rates in both sexes and most age groups, including […]
Long-distance cross-country skiers at increased risk of heart rhythm disturbances
Cross-country skiers who take part in one of the world’s most challenging ski races, the 90 km Vasaloppet in Sweden, are at increased risk of developing arrhythmia – problems with the rate or rhythm of their heart beat – according to a study of nearly 53,000 race participants published online in the European Heart Journal […]
Genetic research clarifies link between hypertension and Vitamin D deficiency
Paris, France: Low levels of vitamin D can trigger hypertension, according to the world’s largest study to examine the causal association between the two. Although observational studies have already shown this link, a large-scale genetic study was necessary before the cause and effect could be proven, researchers told the annual conference of the European Society […]
Diabetes drug shows promise in treatment of neurodegenerative disease
Paris, France: A drug used to control Type II diabetes can help repair the spinal cords of mice suffering from the inherited disease adrenoleukodystrophy which, untreated, leads eventually to a paralysis, a vegetative state and death. This is an important step along the road to the development of a therapy for the human disease for […]
Significant under-use of genetic testing for inherited cancers puts health of entire families at risk
Paris, France: A new study of the use of genetic testing for cancer-causing mutations in affected families in France has found that its take-up is very low. Professor Pascal Pujol, Head of the Cancer Genetics Department, Montpellier University Hospital, Montpellier, France, told the annual conference of the European Society of Human Genetics that analysis of […]
Alzheimer’s disease drugs linked to reduced risk of heart attacks
Drugs that are used for treating Alzheimer’s disease in its early stages are linked to a reduced risk of heart attacks and death, according to a large study of over 7,000 people with Alzheimer’s disease in Sweden. The research, which is published online in the European Heart Journal [1], looked at cholinesterase inhibitors (ChEIs), such […]
Slim women have a greater risk of developing endometriosis than obese women
Women with a lean body shape have a greater risk of developing endometriosis than women who are morbidly obese, according to the largest prospective study to investigate the link. The study, which is published online in Europe’s leading reproductive medicine journal Human Reproduction [1], found that the risk of endometriosis was 39% lower in morbidly […]
Palliative radiotherapy for bone metastases in the elderly has positive effects on pain and quality of life
Geneva, Switzerland: Giving palliative radiotherapy to elderly patients with painful bone metastases can significantly improve their quality of life, a Dutch researcher told the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO). With the number of elderly patients who suffer from metastatic disease on the increase due to the ageing of the population […]
Commonly used drug can limit radiation damage to lungs and heart for cancer patients
Geneva, Switzerland: Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumours in the chest region can be limited by the administration of an ACE inhibitor, a drug commonly used in the treatment of cardiovascular disease, a group of Dutch researchers have found. [1] Common cancers such as breast, oesophagus, lung, and […]
Intensity modulated radiotherapy reduces side effects in patients with early breast cancer
Geneva, Switzerland: Intensity modulated radiotherapy (IMRT) gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented to the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO). IMRT is an advanced, high-precision form of radiotherapy that can deliver an even dose of radiation, […]